Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on H2 Receptor Antagonists. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN1033521A reveals a safer route to Famotidine intermediates using bicyclic amidine salts, eliminating toxic hydrogen sulfide and improving supply chain reliability for pharmaceutical manufacturers.
Novel patent CN103130782A details a hydroxylamine-based route for Lafutidine intermediates, eliminating dihydro impurities and ensuring 99.88% purity for reliable API manufacturing.